Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Apr;66 Suppl 3(Suppl 3):iii3-9.
doi: 10.1093/jac/dkr094.

Changing needs of community-acquired pneumonia

Affiliations
Review

Changing needs of community-acquired pneumonia

Julio Alberto Ramirez et al. J Antimicrob Chemother. 2011 Apr.

Abstract

Community-acquired pneumonia (CAP) is a serious condition associated with significant morbidity and potential long-term mortality. Although the majority of patients with CAP are treated as outpatients, the greatest proportion of pneumonia-related mortality and healthcare expenditure occurs among the patients who are hospitalized. There has been considerable interest in determining risk factors and severity criteria assessments to assist with site-of-care decisions. For both inpatients and outpatients, the most common pathogens associated with CAP include Streptococcus pneumoniae, Haemophilus influenzae, group A streptococci and Moraxella catarrhalis. Atypical pathogens, Gram-negative bacilli, methicillin-resistant Staphylococcus aureus (MRSA) and viruses are also recognized aetiological agents of CAP. Despite the availability of antimicrobial therapies, the recent emergence of drug-resistant pneumococcal and staphylococcal isolates has limited the effectiveness of currently available agents. Because early and rapid initiation of empirical antimicrobial treatment is critical for achieving a favourable outcome in CAP, newer agents with activity against drug-resistant strains of S. pneumoniae and MRSA are needed for the management of patients with CAP.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Clinical course of hospitalized patients with CAP.

References

    1. Heron M, Hoyert DL, Murphy SL, et al. National Vital Statistics Reports. Deaths: Final Data for 2006. April 17, 2009. http://www.cdc.gov/nchs/data/nvsr/nvsr57/nvsr57_14.pdf. (17 August 2010, date last accessed) - PubMed
    1. Niederman MS, McCombs JS, Unger AN, et al. The cost of treating community-acquired pneumonia. Clin Ther. 1998;20:820–37. doi:10.1016/S0149-2918(98)80144-6. - DOI - PubMed
    1. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–72. doi:10.1086/511159. - DOI - PMC - PubMed
    1. DeFrances CJ, Hall MJ. 2005 National Hospital Discharge Survey. Adv Data. 2007;((385)):1–19. - PubMed
    1. Agency for Healthcare Research and Quality. Pneumonia is the Most Common Reason for Hospitalization. http://www.ahrq.gov/research/sep08/0908RA40.htm. (17 August 2010, date last accessed)

Publication types

MeSH terms

Substances